 Orgenesis NASDAQ:ORGS Inc announced that its joint venture JV with Theracell Advanced Biotechnology SA in Greece has been designated a Priority Investment of Strategic National Importance. The global biotech company noted that the designation was awarded by Enterprise Greece, the official Greek national investment and trade promotion agency, which is responsible for the allocation of the government funds. 